EndoBarrier Gastrointestinal Liner

DEVICE5 trials

Sponsors

Morphic Medical Inc., The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, Filip Krag Knop

Conditions

ObesityType 2 Diabetes

Phase 1

A Study of the GI Sleeve for the Treatment of Type 2 Diabetes

CompletedNCT02709577

Morphic Medical Inc.Type 2 Diabetes

Start: 2007-01-31End: 2009-01-31Updated: 2016-12-28

Phase 4

EndoBarrier Versus Intragastric Balloon in Obese Diabetic Patients

The Mediterranean Institute for Transplantation and Advanced Specialized TherapiesObesity, Type 2 Diabetes

Start: 2013-05-31End: 2019-05-31Target: 90Updated: 2015-03-24

Unknown Phase

Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner

CompletedNCT01114438

Morphic Medical Inc.Obesity, Type 2 Diabetes

Start: 2010-10-31End: 2013-07-31Updated: 2017-04-24

The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones

CompletedNCT02360878

Filip Krag KnopObesity, Type 2 Diabetes

Start: 2013-02-28End: 2017-07-31Updated: 2017-08-10

Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity

TerminatedNCT03072901

Morphic Medical Inc.Obesity, Type 2 Diabetes

Start: 2010-12-31End: 2016-02-29Updated: 2017-03-07